XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Operations - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Net revenues $ 8,292,362 $ 9,085,826 $ 30,842,780 $ 27,432,376
Costs and expenses:        
Cost of products sold 988,760 1,323,013 4,425,863 4,609,499
Selling and marketing 4,433,831 4,397,480 12,889,458 12,800,469
Research and development 1,253,367 1,306,095 4,016,842 3,523,535
General and administrative 2,572,066 2,675,380 7,909,996 7,800,435
Amortization 1,009,598 1,078,290 3,021,412 3,288,808
Total costs and expenses 10,257,622 10,780,258 32,263,571 32,022,746
Operating loss (1,965,260) (1,694,432) (1,420,791) (4,590,370)
Interest income 131,583 69,190 384,781 227,777
Other income - insurance proceeds 0 237,089 0 237,089
Interest expense (109,699) (137,374) (383,048) (382,247)
Loss before income taxes (1,943,376) (1,525,527) (1,419,058) (4,507,751)
Income tax expense (5,670) (11,442) (17,011) (34,327)
Net loss (1,949,046) (1,536,969) (1,436,069) (4,542,078)
Net loss (income) at subsidiary attributable to noncontrolling interests 8,282 (7,112) 11,633 (33,878)
Net loss attributable to common shareholders $ (1,940,764) $ (1,544,081) $ (1,424,436) $ (4,575,956)
Loss per share attributable to common shareholders        
Basic (in USD per share) $ (0.13) $ (0.11) $ (0.10) $ (0.32)
Diluted (in USD per share) $ (0.13) $ (0.11) $ (0.10) $ (0.32)
Weighted-average shares outstanding        
Basic (in shares) 14,958,534 14,052,754 14,953,944 14,089,496
Diluted (in shares) 14,958,534 14,052,754 14,953,944 14,089,496